Please provide your email address to receive an email when new articles are posted on . Atezolizumab monotherapy induced objective responses in more than one-third of patients. No treatment-related ...
BEAVERTON, OREGON - April 11, 2014 - Each day at home for Nathalie Traller can be a different routine depending on how she feels. Nathalie Traller, a freshman at Sunset High School, has been diagnosed ...
A 23-year-old woman with an alveolar soft-part sarcoma of her calf with pulmonary metastases unresponsive to chemotherapy is described. Interferon (IFN) alpha-2b induced an impressive tumour response ...
Credit: Thinkstock. The approval was based on data from a phase 2 study that included 49 patients with unresectable or metastatic ASPS. The Food and Drug Administration (FDA) has approved Tecentriq ...
Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily affects adolescents and young adults, who received immunotherapy beyond the ...
Reply to: How to Interpret the Results in a Noninferiority Randomized Trial in Chronic Lymphocytic Leukemia We previously reported initial results of the pivotal phase II trial of atezolizumab for ...
Chugai Pharmaceutical Co., Ltd. announced that it obtained regulatory approval from the Ministry of Health, Labour and Welfare for the anti-cancer agent/humanized anti-PD-L1 monoclonal antibody ...
Results of the phase 1b soft-tissue sarcoma (STS) portion of the global randomized, double-blind, placebo-controlled study of tazemetostat (TAZ) plus doxorubicin (DOX) as frontline therapy for ...
This trial looked cediranib to treat alveolar soft part sarcoma that had spread. The trial was supported by Cancer Research UK. It was open for people to join between 2011 and 2016. The team published ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved atezolizumab for adults and children aged 2 years or older with unresectable or metastatic ...
Rare cancer treatment going well thanks to community support, says Kingston resident A Kingston, Ont., resident says he's finally getting the treatment he needs for a rare cancer he was diagnosed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results